Einstein Aging Study

The Einstein Aging Study (EAS), first funded by the NIA in 1993, has, since its inception, focused on remediable risk factors and biological pathways that lead to cognitive decline, dementing disorders, and the intermediate states that precede them.

Its goals are:

  • To describe the changes in memory and thinking which occur in normal aging.
  • To develop tests that help identify early Alzheimer's disease and individuals at high risk for future disease.
  • To study the causes of Alzheimer's disease.
  • To discover the changes in the brain that cause memory loss and other cognitive symptoms.
  • To help devise treatment strategies that delay or reverse such brain changes.
  • To provide education and information about the aging brain to EAS participants and the community.
  • Overview

    Acronym
    EAS
    Investigators
    Dr. Richard B. Lipton
    Albert Einstein College of Medicine, Montefiore Medical Center
    Dr. Martin Sliwinski
    Penn State University
    Contacts
    Mindy Katz
    Albert Einstein College of Medicine, Montefiore Medical Center

    General Design

    Study design
    Cohort
    Start - End Year
    1993 -
    General Information on Follow Up (profile, frequency)
    After baseline, participants are followed yearly.
    Recruitment Target
    • Individuals
    Number of Participants
    2,600
    Number of Participants with Biological Samples
    2,600

    Access

    Availability of data and biosamples

    Possible Access to Data
    Possible Access to Biosamples
    Other

    Marker Papers

    Katz, M.J. et al. Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord, 2012 Oct-Dec;26(4):335-43.

    PUBMED 22156756

    Timeline

    Population

    EAS population

    The population is composed of men and women who are at least 70 years of age, Bronx residents, non-institutionalized, and English speaking.

    Selection Criteria

    Minimum age
    70
    Countries
    • United States of America
    Territory

    Bronx County, NY

    Health Status
    • Exclusion criteria included visual or auditory impairments that preclude neuropsychological testing, active psychiatric symptomatology that interfered with the ability to complete assessments, and non-ambulatory status. 

    Other Criteria

    Eligible participants were non-institutionalized and English speaking.

    Sources of Recruitment

    General Population
    • Selected sample

    Sample Size

    Number of Participants
    2,600
    Number of Participants with Biological Samples
    2,600

    Data Collection Events

    # Name Data sources Data sources - Biosamples Start End
    0 EAS - Baseline
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    1993 1994
    1 EAS - Follow-up 1
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    1994 1995
    2 EAS - Follow-up 2
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    1995 1996
    3 EAS - Follow-up 3
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    1996 1997
    4 EAS - Follow-up 4
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    1997 1998
    5 EAS - Follow-up 5
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    1998 1999
    6 EAS - Follow-up 6
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    1999 2000
    7 EAS - Follow-up 7
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2000 2001
    8 EAS - Follow-up 8
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2001 2002
    9 EAS - Follow-up 9
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2002 2003
    10 EAS - Follow-up 10
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2003 2004
    11 EAS - Follow-up 11
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2004 2005
    12 EAS - Follow-up 12
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2005 2006
    13 EAS - Follow-up 13
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2006 2007
    14 EAS - Follow-up 14
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2007 2008
    15 EAS - Follow-up 15
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2008 2009
    16 EAS - Follow-up 16
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2009 2010
    17 EAS - Follow-up 17
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2010 2011
    18 EAS - Follow-up 18
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2011 2012
    19 EAS - Follow-up 19
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2012 2013
    20 EAS - Follow-up 20
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2013 2014
    21 EAS - Follow-up 21
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2014 2015
    22 EAS - Follow-up 22
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2015 2016
    23 EAS - Follow-up 23
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2016 2017
    24 EAS - Follow-up 24
    • Questionnaires
    • Cognitive measures
    • Physical measures
    • Biosamples
    • Blood
    2017 2018

    Participating Studies

    Acronym Name Study design Countries

    Harmonization Initiatives Included

    Acronym Name

    Datasets

    Name Data Collection Events Variables

    Areas of Information Collected

    Socio-demographic and economic characteristics
    Death
    Lifestyle and behaviours
    Physical measures and assessments
    Birth, pregnancy and reproductive health history
    Laboratory measures
    Perception of health, quality of life, development and functional limitations
    Cognition, personality and psychological measures and assessments
    Diseases
    Life events, life plans, beliefs and values
    Symptoms and signs
    Preschool, school and work life
    Medication and supplements
    Social environment and relationships
    Non-pharmacological interventions
    Physical environment
    Health and community care services utilization
    Administrative information

    Variables Content Summary

    Areas of Information Collected
    No Areas of Information Collected
    No Scales Collected
    Areas of Information Collected per per Population and Data Collection Event
    No Areas of Information Collected
    No Scales Collected

    Networks

    Acronym Name Harmonization Initiatives Individual Studies
    Last Update: 2023-12-06T17:18:51.553